Matches in Nanopublications for { ?s ?p "[Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3% (2/14) of adenocarcinoma specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP554531.RAXUrgk1HFG6VCTy56eY98n-mbdr7IPuaQJEJ-1e3nWvM130_assertion description "[Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3% (2/14) of adenocarcinoma specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554531.RAXUrgk1HFG6VCTy56eY98n-mbdr7IPuaQJEJ-1e3nWvM130_provenance.
- NP582953.RAltY-MrOVliuCggfHjbLeSiV_-JdC4l8ex-hCIcQb5ks130_assertion description "[Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3% (2/14) of adenocarcinoma specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582953.RAltY-MrOVliuCggfHjbLeSiV_-JdC4l8ex-hCIcQb5ks130_provenance.
- NP395849.RAQRjFIaHJKE4zHtc2aYf4CUiBNbnqjunidnIq8-ugh7Y130_assertion description "[Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3% (2/14) of adenocarcinoma specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395849.RAQRjFIaHJKE4zHtc2aYf4CUiBNbnqjunidnIq8-ugh7Y130_provenance.
- NP789619.RAYwTbg7TaV-BR34ElQijC4dzfJLzvScGByu93SpjXczU130_assertion description "[Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3% (2/14) of adenocarcinoma specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789619.RAYwTbg7TaV-BR34ElQijC4dzfJLzvScGByu93SpjXczU130_provenance.
- NP240832.RA2JsdsfajNRxPPfRzjgeqidrxYJQ66JQj2uAn_dNUh2M130_assertion description "[Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3% (2/14) of adenocarcinoma specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240832.RA2JsdsfajNRxPPfRzjgeqidrxYJQ66JQj2uAn_dNUh2M130_provenance.
- NP554390.RA1f47mlXv2eNG-uG9YkU5VCe3JM4N7h5qJJXHCdbt5iw130_assertion description "[Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3% (2/14) of adenocarcinoma specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554390.RA1f47mlXv2eNG-uG9YkU5VCe3JM4N7h5qJJXHCdbt5iw130_provenance.
- NP565225.RA_CFwKq9XMPBJd1LBczsd3856LpjXRfCjvPC0ES-FOaE130_assertion description "[Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3% (2/14) of adenocarcinoma specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565225.RA_CFwKq9XMPBJd1LBczsd3856LpjXRfCjvPC0ES-FOaE130_provenance.